| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $52,853,390 ) (Continued on the next page) |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK133885 | Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis | 000 | 3 | NIH | 5/7/2024 | $751,132 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA272732 | Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers | 000 | 3 | NIH | 6/21/2024 | $382,471 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA266874 | A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer | 000 | 3 | NIH | 6/26/2024 | $668,834 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01LM013876 | An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs | 001 | 3 | NIH | 5/8/2024 | $37,400 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01LM013876 | An integrated toolkit combining computational systems biology techniques with molecular dynamics simulations to delineate functionality of GPCRs | 000 | 3 | NIH | 3/22/2024 | $336,600 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01ES033514 | Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort | 000 | 3 | NIH | 5/3/2024 | $627,063 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA269569 | BAFF-R CAR T cell therapy for ALL | 001 | 3 | NIH | 4/25/2024 | $33,881 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA269569 | BAFF-R CAR T cell therapy for ALL | 000 | 3 | NIH | 3/15/2024 | $609,861 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA271497 | The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia | 001 | 3 | NIH | 4/17/2024 | $28,680 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA271497 | The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia | 000 | 3 | NIH | 2/2/2024 | $516,258 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R00CA256526 | Investigating the Role of Radiation-induced Cell Death in Innate Lymphoid Cell Activation within Unique Tumor Microenvironments | 001 | 4 | NIH | 4/17/2024 | $24,901 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R00CA256526 | Investigating the Role of Radiation-induced Cell Death in Innate Lymphoid Cell Activation within Unique Tumor Microenvironments | 000 | 4 | NIH | 3/12/2024 | $224,099 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AG072291 | Develop age-relevant glial cellular models using human directly reprogrammed cells | 000 | 4 | NIH | 5/21/2024 | $440,000 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA255250 | Identifying and engaging a universal adjuvant for breaking macrophage immune tolerance in cancer | 000 | 4 | NIH | 6/14/2024 | $409,926 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK125856 | Circulating Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes | 000 | 4 | NIH | 6/14/2024 | $443,154 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI151013 | KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | 001 | 4 | NIH | 5/23/2024 | $84,892 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI151013 | KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | 000 | 4 | NIH | 2/1/2024 | $764,036 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA254271 | Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma | 000 | 5 | NIH | 4/11/2024 | $711,759 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249501 | Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer | 000 | 5 | NIH | 3/25/2024 | $707,468 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249501 | Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer | 001 | 5 | NIH | 4/16/2024 | $39,305 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K08CA245193 | Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care | 000 | 6 | NIH | 4/17/2024 | $237,924 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R33AG059206 | Geriatric Oncology Research Infrastructure to Improve Clinical Care | 002 | 7 | NIH | 6/27/2024 | $631,571 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA262754 | The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma | 000 | 4 | NIH | 6/28/2024 | $381,482 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HD096152 | Mammary Adipocyte Remodeling in Health and Disease | 000 | 5 | NIH | 2/16/2024 | $333,749 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124627 | Bile acids and metabolic surgery | 000 | 5 | NIH | 5/31/2024 | $380,160 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 001 | 5 | NIH | 4/16/2024 | $39,410 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA249460 | Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | 000 | 5 | NIH | 3/11/2024 | $709,370 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01CA250046 | Information flow and state transitions at the system and multi-dimensional scales in leukemia progression | 000 | 5 | NIH | 4/30/2024 | $623,198 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA244576 | Overcoming ibrutinib resistance in mantle cell lymphoma | 001 | 4 | NIH | 4/16/2024 | $22,516 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA244576 | Overcoming ibrutinib resistance in mantle cell lymphoma | 000 | 4 | NIH | 1/29/2024 | $405,279 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL150069 | Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | 001 | 5 | NIH | 6/21/2024 | $56,038 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL150069 | Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | 000 | 5 | NIH | 2/2/2024 | $630,427 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 001 | 5 | NIH | 4/18/2024 | $21,676 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248149 | Role of Protein Arginine Methyltransferase 9 in Acute Myeloid Leukemia Maintenance | 000 | 5 | NIH | 2/19/2024 | $390,165 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248475 | Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | 001 | 5 | NIH | 4/18/2024 | $25,529 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA248475 | Vascular Remodeling in the Bone Marrow Leukemic Niche: A Therapeutic Target? | 000 | 5 | NIH | 3/14/2024 | $459,519 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 001 | 5 | NIH | 4/18/2024 | $21,183 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA240910 | Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia | 000 | 5 | NIH | 4/1/2024 | $381,301 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AG063854 | Defining the Role of Adipogenesis in Age-Associated Adiposity | 000 | 5 | NIH | 4/24/2024 | $360,800 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA240111 | Interdisciplinary Communication Training in Oncology | 001 | 5 | NIH | 4/18/2024 | $90,305 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA240111 | Interdisciplinary Communication Training in Oncology | 000 | 5 | NIH | 2/9/2024 | $203,109 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | T32CA221709 | Cancer Metabolism Training Program | 001 | 6 | NIH | 6/21/2024 | $248,089 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 001 | 6 | NIH | 6/6/2024 | $20,129 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational Targeting the Feed-forward Epigenetic Circuitry in Mixed Lineage Leukemia | 000 | 6 | NIH | 2/2/2024 | $362,340 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA228308 | The role of bile acid metabolomics in graft-versus-host disease | 001 | 7 | NIH | 5/6/2024 | $555,619 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01HL137723 | Role of the unfolded protein response in pathological cardiac remodeling | 000 | 9 | NIH | 5/29/2024 | $563,886 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 001 | 7 | NIH | 4/18/2024 | $32,399 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA217270 | Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care | 000 | 7 | NIH | 2/14/2024 | $291,600 |
| 2024 | 2024 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA205247 | Targeting MicroRNAs to Eradicate Leukemia Stem Cells | 000 | 8 | NIH | 7/15/2024 | $480,469 |
|